Using Public Relations to Launch, Grow and Extend Your Brands

CHAPEL HILL, N.C., April 14 /PRNewswire/ -- Though Public Relations has long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach the consumer has never been greater. New technologies and market changes have greatly expanded the reach and potential of cost-efficient Public Relations through websites, online social networks, blogs and traditional media sources. These mediums have joined the traditional press release as effective and low-cost methods that help drive product sales.

"Using Public Relations to Launch, Grow and Extend your Brands," a just-published benchmarking report from Best Practices, LLC, explores which public Relations activities most effectively educate and inform consumers at different points in a product's lifecycle. This report also provides insights into the most effective Public Relations channels, tactics and call-to-action for reaching consumers of pharmaceutical products. Four case studies of successful products are included in this report to highlight Public Relations tactics at different lifecycle stages: Slentrol (product launch), Flomax (brand-building), Nexium (product maturity) and Fluvirin (patent expiration).

Now available at http://www3.best-in-class.com/rr982.htm, this new study's findings include:

• Using Public Relations Tools for Optimal Advantage
• Public Relations during Pre-Launch
• Public Relations during Launch
• Public Relations during Brand-Building
• The Role of Public Relations in Late-Life Management
• Public Relations and Patent Expiration Management
• Ideal Budget Ratios and Performance Measurements
• Lesson Learned and General Good Practices

A complimentary summary of "Using Public Relations to Launch, Grow and Extend your Brands" is available at http://www3.best-in-class.com/rr982.htm. For more information, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 18 years; our clients include 48 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC